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Criterion-based screening for sexually transmitted infection: sensitivity, specificity, and 
predictive values of commonly used questions. 
 
Précis: 
Standard screening questions to identify increased likelihood of sexually transmitted infection 
are not useful in predicting the presence of infection. 
 
 
Abstract: Background: Practice protocols that mandate pre-screening for sexually transmitted 
infection prior to insertion of an intrauterine device for contraception can pose obstacles for 
women seeking this highly effective method of birth control. Some practices screen for 
presumed risk factors for sexually transmitted infection in order to identify those who may be 
infected, or those in whom laboratory testing should be obtained. The value of such criterion-
based screening is unclear. 
Design: Data from a prospective observational trial of offering the copper intrauterine device for 
emergency contraception were used to assess the value of several screening questions in 
predicting the presence of sexually transmitted infection. Criteria evaluated were age under 25, 
history of a sexually transmitted infection, and having 2 or more sexual partners in the previous 
3 months. The sensitivity, specificity, and likelihood ratio of both positive and negative tests, and 
positive and negative predictive values were calculated for three separate questions, as well as 
for combinations of these three questions.  
Results: There were 197 women who received a copper intrauterine device for emergency 
contraception at the same time they were tested for sexually transmitted infection. In this 
sample, there were 8 cases of Chlamydia trachomatis identified, and no cases of Neisseria 
gonorrhea. The sensitivity of individual and combined questions in identifying those who were 
infected ranged from 0 to 88%; specificity ranged from 37-97%. The positive predictive values 
for single or combined screening questions were in the range of 4-6%. Likelihood ratios for both 
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Conclusion: Standard screening questions used to identify sexually transmitted disease risk 
could presume infection in large numbers of uninfected women and are of little value in 
identifying the women who are truly infected. 
  
INTRODUCTION 
The most effective contraceptive methods are those that minimize the possibility of user 
error such as forgetting to take a pill, receive a repeat injection, or replace a patch. Emphasis on 
long-acting reversible contraception is seen as an important means for reducing unintended 
pregnancies and abortions. Intrauterine contraceptive devices (IUDs) are long-acting reversible 
contraceptive methods. The two types of IUDs available in the United States are the copper T 
380A (brand name ParaGard) and the levonorgestrel intrauterine system (brand name Mirena). 
However these IUDs are only used by 5.5% of women using contraception in the United States.1 
Removing barriers to IUD use is an important step toward more widespread use of these 
methods. Indeed, a recent large cohort study of 10,000 women of reproductive age 
demonstrated that once appropriate information is given and financial and other barriers are 
removed, 56% of women will choose intrauterine contraception as a family planning method.2 
The United States Medical Eligibility Criteria for Contraceptive Use3  state that  current 
purulent cervicitis or infection with Chlamydia trachomatis or Neisseria gonorrhea are 
contraindications to initiation of  any intrauterine device. However these guidelines also point out 
that there is no evidence to support an increased risk of upper genital tract infection among 
women undergoing IUD insertion in the presence of a sexually transmitted infection (STI). A 
systematic review of observational studies demonstrated that women with asymptomatic 
infection with N. gonorrhoea or C. trachomatis who have an IUD inserted have a higher risk of 
salpingitis than do uninfected women having an IUD inserted, but the  absolute risk of infection 
was low for both groups (0–5% for those with STIs and 0–2% for those without). 4 In another 
review, Grimes suggested that the risk was similar to that of infected women not having an IUD 
inserted, that development of salpingitis appears to be due to the presence of infection, not to 
the insertion of the IUD, and choice of inappropriate comparison groups has exaggerated the 
appearance of risk. 5 
Unfortunately it is unlikely that the clinical question of actual (as opposed to presumed) 
risk can ever be addressed in randomized trials, and surveys have shown that common 
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appropriate only in a restricted set of circumstances. 6,7 For example, many local practice 
patterns continue to mandate pre-testing for current sexually transmitted infection before an IUD 
can be inserted. Such policies generally require two visits to obtain an intrauterine contraceptive 
method: one visit for assessment and screening, and a second visit for IUD insertion once a 
negative screening test has been returned. This two visit requirement creates barriers related to 
time, cost, and access for women who wish to obtain an effective contraceptive method. In 
addition, such protocols reduce opportunities to provide an excellent emergency contraceptive 
method, the copper intrauterine device.   
Some authoritative clinical practice guidelines point to a paucity of data about the need 
for routine screening in women at low risk of STIs, and advise that, for women at higher risk, it is 
reasonable to screen at the time of insertion and treat if results are positive. 8 Categorization as 
to whether a woman is at low or higher risk of STI by predicting the likelihood of an infection 
from her history could eliminate the need for screening for some women and could increase 
opportunities for same day insertion.  
Commonly cited criteria for STI risk include: less than 25 years of age, history of a 
sexually transmitted infection, and a history of more than one sexual partner in the prior 3 
months. 8 9,10 The purpose of this study was to evaluate how well these characteristics could be 
used to predict sexually transmitted infection in sexually active women who chose the copper 
IUD as an emergency contraceptive method and planned to continue its use.  
 
METHODS 
This study was a secondary data analysis. Data were obtained from a previously 
reported prospective observational trial of women choosing the copper IUD for emergency 
contraception and the pilot study that preceded it.11,12 The studies were approved by the 
University of Utah Institutional review board. In brief, study enrollment occurred at two family 
planning clinics in Utah during two distinct periods: from April 2008, to July 2008 and from 
November 2009 to July 2010. Women aged 18-30 years seeking emergency contraception were 
offered participation in a study comparing oral levonorgestrel pills to the copper IUD.  Potential 
participants received scripted counseling on both methods that compared their efficacy rates as 
emergency contraceptives and the benefit of continuing highly effective contraception with the 
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The following exclusion criteria were employed in the original study: current pregnancy, 
pelvic inflammatory disease or a septic abortion within the past 3 months, infection with C. 
trachomatis or N. gonorrhea in the last 60 days, current sexual behavior suggesting a high risk 
for pelvic inflammatory disease (multiple sexual partners without the use of a barrier method for 
STI prevention), allergy to copper or Wilson's disease (for participants selecting copper IUD), 
allergy to levonorgestrel (for participants selecting the oral form of emergency contraception), 
and abnormalities of the uterus that distort the uterine cavity including leiomyomas, 
mucopurulent cervicitis, an IUD already in place, genital bleeding of unknown etiology, ovarian, 
cervical or endometrial cancer, or a small uterine cavity (<6 cm).   
The women who chose the copper device had the device inserted at the time of their 
visit by a qualified provider. Testing for C. trachomatis and N. gonorrhea was done at the time of 
the insertion; specimens were sent to the laboratory as per clinic protocols. Those women 
whose tests were positive were recalled for treatment.   
Data on common criterion-based screening for sexually transmitted infection risk were 
collected on all or most participants including history of prior STI, age < 25 years, and 2 or more 
sexual partners in the prior 3 months. Laboratory results for all women who requested 
immediate IUD insertion for emergency contraception were then compared to these data to 
determine the sensitivity, specificity and likelihood ratios of the screening questions, and the 
predictive values of the questions in identifying sexually transmitted infection. The three criteria 
were evaluated separately, and composite screening criteria, based on having two or more of 
the criteria, were also evaluated. 
Screening test parameters evaluated were sensitivity, specificity, and positive and negative 
predictive values. These were calculated according to standard definitions (Table 1). Likelihood 
ratios are most commonly used in the setting of evaluating a diagnostic test, rather than a 
screening test. Nonetheless these were also calculated in the interest of providing a full picture 
of test performance.  
INSERT TABLE 1 ABOUT HERE 
RESULTS 
A total of 605 women presented for emergency contraception during the original study, 
57 for the pilot study and 548 for the prospective trial. Of these, 23 women from the pilot study 
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the visit (n = 199). All women had STI testing at the time of insertion; there were 8 positive 
laboratory tests for C. trachomatis and none for N. gonorrheae. Two women had indeterminate 
or equivocal tests and did not return for re-test and follow-up; diagnosis was thus not available. 
The overall prevalence of STI in the evaluable sample was 4.1% (8/197). All women with 
positive tests were recalled for treatment. They were treated without removing the IUD; there 
were no cases of upper genital tract infection in this group. Demographic characteristics of the 
study sample are presented in Table 2. 
INSERT TABLE 2 ABOUT HERE 
Table 3 provides the results of the various screening questions according to whether or not the 
woman had a positive laboratory test for a STI. Table 4 presents the sensitivity, specificity, 
predictive values, and likelihood ratios for each question. Results were recalculated assuming 
that the two women with equivocal tests had positive tests and did not change these test 
parameters in any appreciable way. 
INSERT TABLES 3 and 4 ABOUT HERE 
DISCUSSION 
This study attempted to quantify the usefulness of criterion-based screening, based on 
age, STI history, and number of sexual partners, in predicting which women presenting for an 
IUD will actually have a sexually transmitted infection. Criterion-based screening, if it proved to 
have good sensitivity, specificity, and predictive values, could facilitate on-demand IUD insertion 
and reduce costs of making multiple visits. Unfortunately these commonly used criteria had 
minimal usefulness in this regard.  
Of the screening questions, only one (age <25) had a sensitivity of greater than 80% in 
correctly identifying women with C. trachomatis. As is often true however, this came at the 
expense of poor specificity (37%) and the false positive attribution of a likely STI to a large 
number of women who were in fact free of infection. Most of the single and combined questions 
had sensitivities below 50% (less than a 1 in 2 chance of being correct).  
Specificity, or correct attribution of disease-free status to uninfected women, was in the 
70% range or lower for single questions and in some cases lower even than 50%. Combining 
the questions provided specificities upward of 80-90%, but this came at the expense of 
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indicated that all women with infection were falsely presumed to be negative for STI even 
though the risk of falsely labeling uninfected women as positive was low. 
 Positive predictive values in the range of 4-6% mean that the probability someone who 
answered positively to any of these screening questions had a minimal risk of actually being 
infected; indeed the prediction value was hardly different from the overall prevalence of STI in 
the women seeking IUDs in this sample (4%). Positive responses to the screening questions 
were of little value in actually predicting the presence of cervical infection, and had they been 
used as screening questions would have denied same day IUD insertion to anywhere from 25% 
to 65% of women requesting it. Negative predictive values were all above 95%, suggesting that 
negative response can provide some confidence that women are at low risk for STI and can 
have an IUD inserted without much concern about infection. Whether any of these predictive 
values are at a level deemed important to provide or deny IUD insertion on the day of the visit is 
likely a matter for provider or program preference or philosophy.  
 The positive predictive value of a screening test depends in large measure on the 
background prevalence or the a priori probability that a person actually has the condition of 
interest. Assuming that a 4% background prevalence of STIs seen here might be lower than in 
some other service programs in the United States, we used the sensitivity and specificity of 
these screening questions in a scenario of higher STI prevalence. In an artificially created 
sample of 200 women in which the prevalence of STI was set at 10%, the positive predictive 
value of the criterion related to a history of STI was between 9 and 10%; the positive predictive 
value of the criterion related to age was 13-14%, and the positive predictive value of the 
criterion related to number of sexual partners was 14-15%. Even in this scenario, the likelihood 
that someone with a positive test actually had an STI was only 1-2 out of every 10 women.  
 Likelihood ratios were similarly not useful. In general, likelihood ratios are applied to the 
pre-test probability of a condition (in this scenario, essentially the background prevalence of the 
condition in the community or sample in the setting of screening). Depending on whether the 
test is positive or negative, the likelihood ratio increases or decreases the post-test probability 
that a disease is actually present. A likelihood ratio for a positive test that is greater than 1 
produces a post-test likelihood of having the condition that is higher than the pre-test likelihood 
(ie, a positive test is more likely to be seen in an infected person than in one who is uninfected). 
However, in the range of 1-2, which was the case for all of these questions and question 
combinations, likelihood ratios for positive tests have negligible effects in changing the post-test 
probability; even likelihood ratios between 2 and 5 will generate only small changes in the post-
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diagnosis given a positive test, a likelihood ratio should be between 5 and 10, and a ratio of 10 
or more is needed to change the post-test probability in a large and conclusive way. None of 
these LRs for positive screening questions tests were high enough to change the post test 
probability in more than a small or negligible way.  
Likelihood ratios for negative tests operate in a similar fashion. In the range of 1-0.5, 
likelihood ratios for a negative test result will have negligible effects in changing the post-test 
probability of the condition and between 0.5 and 0.2 they generate only small changes in the 
post-test probability. In order to be useful the likelihood ratio for a negative test should be 
between 0.2 and 0.1 to moderately change the probability of disease (given a negative test 
result), and less than 0.1 to change this probability in a large and conclusive way.  Again, none 
of the likelihood ratios for negative responses to the single screening questions changed the 
post test probability in more than a small or negligible way. All of these changes in likelihood 
ratios can be visualized rather than calculated using an online nomogram from the Centre for 
Evidence Based Medicine:  http://www.cebm.net/index.aspx?o=1161. 
 Morrison et al13 evaluated several algorithms for their usefulness in predicting STI in 
women. The algorithms, based on criterion-based screening questions similar to ours, were 
developed from data collected from women in Kenya, and then tested in family planning clinic 
databases from Kenya, Jamaica and the United States. An unweighted algorithm that asked 
age, living with partner, education, bleeding between periods, number of sex partners, and 
condom use proved the most predictive. In the United States sample, the overall prevalence of 
STI was 5.7%; a score of 3 or more on the algorithm produced a post-test probability of 10-11% 
and had a LR of 2. The prevalence of STI in this sample was 1-2% higher than in our sample, 
but the performance of their algorithm was similar to the hypothetical scenario we created which 
postulated a background STI prevalence if 10%. It may be that adding more questions could 
improve the predictive value of criterion-based screening questions, but the questions asked in 
our study were the most likely to be routinely collected in our clinics. In the final analysis 
however, the post-test probabilities using Morrison’s expanded criteria in a US based sample 
still did not exceed 11%, or about a 1 in 10 probability that a woman who tests positive on the 
criterion-based screen would actually have an STI. If IUD insertion is delayed for STI test 
results, potentially 9 of 10 women interested in an IUD would be denied their contraceptive 
method of choice unless they returned for another visit. Family planning programs and providers 
need to decide what level of probability of STI would be used to deny same day IUD insertion, 
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The present study is limited by its location and convenience sample nature; all women 
were requesting emergency contraception and represent those willing to consider an IUD. This 
was a secondary analysis and eligibility criteria were established for the parent study, not 
specifically for this one. Thus those with current behavior suggesting a high risk for pelvic 
inflammatory disease (multiple sexual partners without the use of a barrier method for STI 
prevention) were excluded. The screening questions assessed were the ones that had been 
collected in the parent study, but also represent commonly cited screening criteria for STI risk. 
3,4,5 While this sample is clearly self-selected on a number of parameters, and might be 
considered relatively low risk, it does represent a population of women interested in and 
potentially eligible for same day IUD insertion.   
Removing barriers to IUD insertion will improve uptake of this long acting reversible 
contraceptive method, but providers need to be cautious about safety. If the same day IUD 
insertion is offered, the woman should be medically eligible according to practice standards set 
by the US Medical Eligibility Criteria for Contraceptive Use. 3 These standards state that 
initiation of the IUD is contraindicated in the presence of current infection with C. Trachomatis or 
N. Gonorrhea. However, these guidelines also acknowledge that there is no solid evidence that 
IUD insertion in women with these STIs increases their risk for pelvic inflammatory disease 
(PID) over the risk of PID in women with STIs who do not have an IUD inserted. Recognizing 
the small sample size in the current study, it is noted that those with positive tests were recalled 
for treatment without removing the IUD and there were no cases of upper genital tract infection 
in the group with positive tests. To reduce barriers to IUD insertion, authoritative guidelines state 
that STI testing can be done at the time of IUD insertion, and those women who test positive 
recalled for prompt treatment. 8 Should an infection be diagnosed, most authorities suggest 
there is no need to remove the IUD unless symptoms fail to improve or worsen on appropriate 
therapy. 14 Nelson15 has criticized many of the published contraindications to IUD use found  in 
product labeling and guidelines of specialty groups as being overly restrictive, and asserts that a 
condition should be listed as a contraindication only if the associated risk exceeds that of 
pregnancy. She further suggests that practices review their lists of contraindications to ensure 
they are evidence-based. 
 
CONCLUSION 
Requiring STI testing before scheduling an IUD insertion is an obstacle to delivering on-
demand care. Attempting to triage testing based on categorizing women as being at low or high 
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responses to screening questions such as those evaluated in this study may provide the 
clinician with some confidence that cervical infection is unlikely, but positive responses are not 
useful in identifying the presence of infection. In fact the use of such criterion-based screening 
may deny many healthy women on-demand access to an IUD. A rapid point of care STI test 
would better facilitate the STI screening process prior to IUD insertion. Data from a large group 
of women undergoing simultaneous STI screening and IUD insertion may provide additional 
information on infection risk in this setting.16 Until we have such tests and information, however, 
screening and insertion can be done simultaneously, and is recommended by authoritative 
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TABLE 1: Definitions of test parameters used in this study. 
Sensitivity The probability that a person with the target condition will have a positive 
test.  
This is calculated as the proportion of those with a sexually transmitted 
infection (as determined by laboratory testing) who had a positive criterion-
based screening test. 
This is represented as all true positive tests (in the numerator) divided by all 
infected women (in the denominator). 
 
Specificity The probability that a person free of the target condition will have a negative 
test. 
This is calculated as the proportion of women without a sexually transmitted 
infection who had a negative criterion-based screening test. 
This is represented as all true negative tests (in the numerator) divided by all 




The probability that someone with a positive criterion-based test actually has 
the target condition. 
This is calculated as the proportion of those with a positive criterion-based 
screening test who actually had a sexually transmitted infection (as 
determined by laboratory testing). 
This is represented as all true positive tests (in the numerator) divided by all 
positive tests (in the denominator). 
Note that both sensitivity and positive predictive value have “true positive 
tests” in the numerators; the difference is the denominator on which the 




The probability that someone with a negative criterion-based test result is 
actually free of the target condition. 
This is calculated as the proportion of women with a negative criterion-based 
screening test who did not have a  sexually transmitted infection. 
This is represented as all true negative tests (in the numerator) divided by all 
negative tests (in the denominator). 
Note that both specificity and negative predictive value have “true negative 
tests” in the numerators; the difference is the denominator on which the 
percent is calculated. 
 
Likelihood ratio 
for a positive 
test (LR+) 
The likelihood that a positive test result would be seen in a person with the 
condition compared to the likelihood that the same result would be seen in a 
person without the condition. 
This is the ratio of true positives to false positives [sensitivity/(1-specificity)]. 
 
Likelihood ratio 
for a negative 
test (LR-) 
The likelihood that a negative test result would be seen in a person with the 
condition compared to the likelihood that that same result would be seen in a 
person without the condition. 
This is the ratio of false negatives to true negatives [(1-sensitivity)/specificity]. 
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Table 2: Demographic profile of 197 women requesting same day insertion of IUD for 
Emergency Contraception 
Variablea N (%) 
Age<25 yrs  127 (65) 
History of a previous STI  51 (26) 
Reports 2 or more sexual partners in 
previous 3 months  (n=175) 
52 (30) 
Race/Ethnicity (n = 162)  
   White 135 (83) 
   Asian American 5 (3) 
   Native Alaskan/Pacific Islander 5 (3) 
   Native American 6 (4) 
   Black 2 (1) 
   Other 9 (6) 
   Hispanic Ethnicity  43 (27) 
Annual Income (n = 194)  
   < $20,000 127 (65) 
   $20,001 to $40,000 52 (27) 
   $40,001 to $60,000 10 (5) 
   $60,001 to $80,000 4 (2) 
  > $80,001 1 (1) 
Insurance (n = 193)  
   Private 71 (37) 
   Medicaid 13 (7) 
  None 109 (56) 
Nulligravid (n = 190)  
   Yes 86 (45) 
   No 104 (55) 
Marital Status (n = 177)  
   Single, never married 115 (65) 
   Married 17 (10) 
   Divorced 7 (4) 
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   Widowed 0 (0) 
   Single, living with partner 33 (19) 
Employment Status (n = 182)  
   Full-time 70 (38) 
   Student 38 (21) 
  Unemployed 29 (16) 
   Homemaker 9 (5) 
   Part-time 36 (20) 
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TABLE 3:  Results of screening question responses in relation to presence of confirmed 
current sexually transmitted infection 






% with Positive 
Screen who had 
STI 
 
Positive History of STI 2 49 51  3.9% 
Age under 25 7 120 127 5.5% 
2 or more partners 3 49 52 5.8% 
Age <25 AND history of  STI 2 25 27 7.4% 
Age <25 AND 2 or more partners 2 29 31 6.5% 
History of STI AND 2 or more 
partners 
0 13 13 0 
Age <25  AND History of STI AND 2 
or more partners 
0 5 5 0 
STI: Sexually Transmitted Infection 
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LR of a 
positive 
test 
LR of a 
negative 
test 
History of STI 25% 74% 4% 96% 0.96 1.01 
Age < 25 88%  37%  6% 99% 1.4 0.32 
2 or more partners 43%  71%  6% 97% 1.5 0.8 
Age <25 AND hx STI 25%  87%  7% 96% 1.9 0.86 
Age <25 AND 2 or more partners 29%  83%  6% 96% 1.7 0.86 
Hx STI AND 2 or more partners 0  93%  0 96% - 1.08 
Age <25  AND Hx STI AND 2 or more 
partners 
0  97%  0 96% - 1.03 
 
 
